Healthcare provider profile · identity verified

Matthew Mathias

Family Practice · DURHAM, NC · NPI 1316022643

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	276	77
Rosuvastatin Calcium	Rosuvastatin Calcium	256	74
Amlodipine Besylate	Amlodipine Besylate	255	70
Lisinopril	Lisinopril	206	51
Levothyroxine Sodium	Levothyroxine Sodium	181	41
Gabapentin	Gabapentin	149	32
Omeprazole	Omeprazole	128	30
Tamsulosin Hcl	Tamsulosin Hcl	128	31
Metoprolol Succinate	Metoprolol Succinate	125	36
Valsartan	Valsartan	124	27
Spironolactone	Spironolactone	108	31
Metformin Hcl Er	Metformin Hcl	107	32
Albuterol Sulfate Hfa	Albuterol Sulfate	100	23
Meloxicam	Meloxicam	91	22
Eliquis	Apixaban	90	20
Furosemide	Furosemide	83	21
Allopurinol	Allopurinol	80	20
Pantoprazole Sodium	Pantoprazole Sodium	76	21
Finasteride	Finasteride	72	18
Trazodone Hcl	Trazodone Hcl	68	17
Potassium Chloride	Potassium Chloride	60	17
Sertraline Hcl	Sertraline Hcl	60	14
Telmisartan	Telmisartan	60	20
Celecoxib	Celecoxib	55	22
Fluticasone Propionate	Fluticasone Propionate	54	25
Glipizide Er	Glipizide	50	13
Losartan Potassium	Losartan Potassium	50	18
Famotidine	Famotidine	47	13
Clonazepam	Clonazepam	45	12
Hydrochlorothiazide	Hydrochlorothiazide	45	13
Pravastatin Sodium	Pravastatin Sodium	42	12
Escitalopram Oxalate	Escitalopram Oxalate	41	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	39	suppressed
Mirtazapine	Mirtazapine	39	11
Ezetimibe	Ezetimibe	38	11
Montelukast Sodium	Montelukast Sodium	38	suppressed
Jardiance	Empagliflozin	37	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	36	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	36	suppressed
Valacyclovir	Valacyclovir Hcl	36	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	36	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Meclizine Hcl	Meclizine Hcl	35	12
Mounjaro	Tirzepatide	35	suppressed
Prednisone	Prednisone	34	19
Bupropion Xl	Bupropion Hcl	33	suppressed
Metformin Hcl	Metformin Hcl	31	suppressed
Ozempic	Semaglutide	31	suppressed
Simvastatin	Simvastatin	31	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	27
Chlorthalidone	Chlorthalidone	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Atenolol	Atenolol	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Colchicine	Colchicine	22	15
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Trulicity	Dulaglutide	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Carvedilol	Carvedilol	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Ondansetron Odt	Ondansetron	18	12
Enalapril Maleate	Enalapril Maleate	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Benazepril Hcl	Benazepril Hcl	16	suppressed
Mupirocin	Mupirocin	16	13
Telmisartan-Amlodipine	Telmisartan/Amlodipine	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Nitroglycerin	Nitroglycerin	14	11
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Diazepam	Diazepam	13	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Baclofen	Baclofen	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Indapamide	Indapamide	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error